Efficacy of buparlisib according to PIK3CA mutation status in recurrent or metastatic head and neck squamous cell carcinoma: A multicenter phase II trial.

Saved in:
Bibliographic Details
Title: Efficacy of buparlisib according to PIK3CA mutation status in recurrent or metastatic head and neck squamous cell carcinoma: A multicenter phase II trial.
Authors: Gauduchon T; Department of medical oncology, Centre Léon Bérard, Lyon, France. Electronic address: Thibault.gauduchon@lyon.unicancer.fr., Digue L; Department of medical oncology, Saint André Hospital Group, Bordeaux, France., Ferlay C; Direction of Clinical Research and Innovation, Centre Léon Bérard, Lyon, France., Treilleux I; Centre Léon Bérard, Lyon, France., Wang Q; Centre Léon Bérard, Lyon, France., Attignon V; Centre Léon Bérard, Lyon, France., Lefebvre G; Centre Oscar Lambret, Lille, France., Kotecki N; Department of Medical Oncology, Institut Jules Bordet, Bruxelles, Belgium., Daste A; Saint-André Hospital, Bordeaux, France., Even C; Institut Gustave Roussy, Villejuif, France., Couchon-Thaunat S; Centre Léon Bérard, Lyon, France., Guyennon A; Radiology department, Centre Léon Bérard, Lyon, France., Peyrade F; Department of medical oncology, Centre Antoine Lacassagne, Nice, France., Cupissol D; Department of medical oncology, Institut du Cancer de Montpellier, Montpellier, France., You B; Lyon Sud Hospital, Lyon, France., Tourneau CL; Institut Curie, Paris, France., Tabone-Eglinger S; Plateforme de Gestion des Echantillons Biologiques, Centre Léon Bérard, Cancer Research Center of Lyon, Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286 Lyon, France., Garin G; Direction of Clinical Research and Innovation, Centre Léon Bérard, Lyon, France., Pérol D; Direction of Clinical Research and Innovation, Centre Léon Bérard, Lyon, France., Fayette J; Department of medical oncology, Centre Léon Bérard, Lyon, France.
Source: Oral oncology [Oral Oncol] 2026 Jul; Vol. 178, pp. 108004. Date of Electronic Publication: 2026 May 13.
Publication Type: Journal Article; Clinical Trial, Phase II; Multicenter Study
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 9709118 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0593 (Electronic) Linking ISSN: 13688375 NLM ISO Abbreviation: Oral Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1879-0593
DOI:10.1016/j.oraloncology.2026.108004